US · PTHL
Pheton Holdings Ltd Class A Ordinary Shares
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Beijing
- Website
- ftzy.com.cn
Price · as of 2024-12-31
—
Market cap 7.9M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $74.80 | — |
| Intrinsic Value(DCF) | $1.15 | — |
| Graham-Dodd Method(GD) | $0.23 | — |
| Graham Formula(GF) | $1.00 | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $0.00 | $0.03 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $2.30 | $74.80 | $0.39 | $0.23 | $1.00 |
AI valuation
Our deep-learning model estimates Pheton Holdings Ltd Class A Ordinary Shares's (PTHL) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $74.80
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.15
— upside
Graham-Dodd
$0.23
— upside
Graham Formula
$1.00
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| PTHL | Pheton Holdings Ltd Class… | $0.55 | 7.9M | +13,407% | +108% | -59% | +80% | -44.29 | 4.73 | 65.28 | -39.57 | -20.83 | 4.73 | 85.04% | -171.80% | -147.48% | -20.35% | -297.84% | -15.84% | 0.04 | — | 12.40 | 12.01 | 10.02 | 21265.00% | -2870.00% | 111922.00% | -2.65% | -1.44 | -300.11% | 0.00% | 0.00% | 19.99% | -30.32 | -30.09 | 52.09 | 33.27 |
| BMRA | Biomerica, Inc. | $2.58 | 7.4M | +7,094% | -52% | — | — | -1.44 | 1.74 | 1.35 | -1.10 | -0.29 | 1.84 | 9.38% | -96.72% | -93.64% | -92.99% | -191.32% | -65.44% | 0.11 | — | 2.80 | 1.80 | 0.41 | 50000.00% | -192.00% | -2918.00% | -54.28% | -2.21 | -144.43% | 0.00% | 0.00% | 0.00% | -1.01 | -1.34 | 0.98 | -11.52 |
| DHAI | DIH Holding US, Inc. | $1.82 | 3.81M | +1,508% | +20% | — | — | -903.76 | -211.15 | 124.73 | -1104.70 | — | -211.15 | 51.24% | -7.74% | -13.80% | 24.90% | 20.72% | -27.77% | -0.32 | -15.34 | 0.49 | 0.12 | -1.41 | -2412.00% | -250.00% | -19379.00% | -0.06% | -0.10 | 19.94% | 0.00% | 0.00% | 0.03% | -1614.12 | -1677.58 | 124.89 | 72.12 |
| IINN | Inspira Technologies Oxy … | $0.91 | 23.26M | — | — | — | — | -1.42 | 3.64 | — | -1121.82 | — | 3.64 | 0.00% | — | — | -219.74% | 7.39% | -127.19% | 0.58 | — | 2.02 | 1.71 | 234.68 | -9994.00% | — | -426.00% | -60.68% | -2.78 | -6254.43% | 0.00% | 0.00% | 0.00% | 1104.79 | -1.31 | — | -8.52 |
| LFWD | Lifeward Ltd. | $0.56 | 8.72M | +1,309% | +347,698% | — | — | -0.49 | 0.75 | 0.55 | -0.32 | -1.71 | 1.25 | 32.01% | -76.19% | -112.78% | -88.56% | -118.09% | -61.79% | 0.05 | -152.76 | 2.08 | 1.27 | 0.24 | 2857.00% | 8524.00% | 468.00% | -153.36% | -2.12 | -131.16% | 0.00% | 0.00% | 0.00% | -0.41 | -0.37 | 0.32 | -12.27 |
| NEUP | Neuphoria Therapeutics In… | $4.40 | 8.27M | — | +156% | +81% | — | -0.05 | 0.67 | 0.81 | 7.72 | -0.04 | 2.28 | 95.76% | -7.21% | -2.36% | -1594.53% | -12.04% | -1039.93% | 0.01 | — | 3.56 | 3.37 | 79.71 | 13000.00% | — | -62605.00% | 400.22% | 12.04 | 1219.86% | 0.00% | 0.00% | 46.80% | 1.20 | -0.03 | -0.09 | -7.06 |
| PAVM | PAVmed Inc. | $0.35 | 6.09M | +306,826% | +29,017% | +172,865% | +1,028,629% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
| RNAZ | TransCode Therapeutics, I… | $9.57 | 7.98M | — | — | — | — | -0.93 | -7.75 | — | -0.61 | — | -7.75 | 0.00% | — | — | 8866.96% | 369.89% | -268.85% | -0.02 | -584.07 | 2.56 | 2.10 | 0.36 | -9864.00% | — | -2624.00% | -85.33% | -4.81 | 315.50% | 0.00% | 0.00% | 22.07% | -0.63 | -0.74 | — | -17.50 |
| SINT | Sintx Technologies, Inc. | $3.47 | 9.57M | +16,195% | -62% | — | +17,893% | -0.22 | 0.63 | 1.98 | -0.30 | — | 0.64 | 34.91% | -1127.37% | -884.75% | -174.07% | -193.62% | -88.98% | 1.03 | -484.38 | 2.41 | 1.91 | -0.04 | -2178.00% | -5257.00% | -3628.00% | -378.55% | -4.36 | -128.63% | 0.00% | 0.00% | 40.16% | -0.21 | -0.31 | 2.32 | -46.07 |
| SSKN | STRATA Skin Sciences, Inc… | $1.70 | 7.09M | +3,178% | -40% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
| XAIR | Beyond Air, Inc. | $1.88 | 9.82M | +3,062% | -19% | — | — | -0.27 | 0.95 | 3.47 | -0.42 | — | 1.04 | -44.89% | -1202.08% | -1258.43% | -250.98% | -332.73% | -111.42% | 0.86 | -14.75 | 3.20 | 1.56 | -0.17 | -6210.00% | 21967.00% | -2859.00% | -342.82% | -7.64 | -329.47% | 0.00% | 0.00% | 0.00% | -0.40 | -0.40 | 4.76 | -17.17 |
About Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.
- CEO
- Jianfei Zhang
- Employees
- 10
- Beta
- 4.98
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.15 ÷ —) − 1 = — (DCF, example).